Skip to Content

137 Results Found

  • Article
  • Open Access
1 Citations
3,825 Views
32 Pages

Glucagon and Glucose Availability Influence Metabolic Heterogeneity and Malignancy in Pancreatic Neuroendocrine Tumour (pNET) Cells: Novel Routes for Therapeutic Targeting

  • Bárbara Ferreira,
  • Isabel Lemos,
  • Cindy Mendes,
  • Beatriz Chumbinho,
  • Fernanda Silva,
  • Daniela Pereira,
  • Emanuel Vigia,
  • Luís G. Gonçalves,
  • António Figueiredo and
  • Jacinta Serpa
  • + 1 author

25 June 2025

Cancer metabolism is a hallmark of cancer. However, the impact of systemic metabolism and diet on tumour evolution is less understood. This study delves into the role of glucagon, as a component of the pancreatic microenvironment, in regulating featu...

  • Case Report
  • Open Access
3 Citations
5,984 Views
7 Pages

Ovarian Clear Cell Carcinoma and Mature Cystic Teratoma Transformed to PNET and Carcinosarcoma: A Case Report with an Immunohistochemical Investigation

  • Mikiko Matsuo,
  • Chiemi Saigo,
  • Tamotsu Takeuchi,
  • Akane Onogi,
  • Naoki Watanabe,
  • Shinsuke Aikyo,
  • Hiroshi Toyoki,
  • Hiroyuki Yanai and
  • Takuji Tanaka

Ovarian tumors include neoplasms derived from somatic cells and germ cells, including teratoma. Sometimes, tumors of the somatic cell type may develop from teratoma, causing diagnostic perturbation. We experienced a case of a tumor composed of severa...

  • Review
  • Open Access
13 Citations
4,921 Views
20 Pages

27 November 2021

Pancreatic neuroendocrine tumours (pNETs) represent 1 to 2% of all pancreatic neoplasm with an increasing incidence. They have a varied clinical, biological and radiological presentation, depending on whether they are sporadic or genetic in origin, w...

  • Systematic Review
  • Open Access
5 Citations
2,357 Views
24 Pages

Robotic Versus Laparoscopic Versus Open Surgery for Non-Metastatic Pancreatic Neuroendocrine Tumors (pNETs): A Systematic Review and Network Meta-Analysis

  • Stelios-Elion Bousi,
  • Marinos Zachiotis,
  • Michail Papapanou,
  • Maximos Frountzas,
  • Dimitrios Symeonidis,
  • Dimitrios Raptis,
  • Basilios Papaziogas,
  • Konstantinos Toutouzas,
  • Evangelos Felekouras and
  • Dimitrios Schizas

22 October 2024

Background: This systematic review, using pairwise and network meta-analyses, aimed to compare the intraoperative, short-term, and long-term postoperative outcomes of minimally invasive surgery (MIS) and open surgery (OS) for the management of pancre...

  • Review
  • Open Access
13 Citations
3,653 Views
14 Pages

Contrast Enhanced EUS for Predicting Solid Pancreatic Neuroendocrine Tumor Grade and Aggressiveness

  • Gianluca Franchellucci,
  • Marta Andreozzi,
  • Silvia Carrara,
  • Luca De Luca,
  • Francesco Auriemma,
  • Danilo Paduano,
  • Federica Calabrese,
  • Antonio Facciorusso,
  • Valeria Poletti and
  • Benedetto Mangiavillano
  • + 10 authors

Pancreatic neuroendocrine tumor (PNET) behavior assessment is a daily challenge for physicians. Modern PNET management varies from a watch-and-wait strategy to surgery depending on tumor aggressiveness. Therefore, the aggressiveness definition plays...

  • Review
  • Open Access
47 Citations
11,645 Views
51 Pages

Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets

  • Chandra K. Maharjan,
  • Po Hien Ear,
  • Catherine G. Tran,
  • James R. Howe,
  • Chandrikha Chandrasekharan and
  • Dawn E. Quelle

12 October 2021

Pancreatic neuroendocrine tumors (pNETs) are unique, slow-growing malignancies whose molecular pathogenesis is incompletely understood. With rising incidence of pNETs over the last four decades, larger and more comprehensive ‘omic’ analyses of patien...

  • Article
  • Open Access
3 Citations
2,391 Views
19 Pages

MUC1-C Dependence for the Progression of Pancreatic Neuroendocrine Tumors Identifies a Druggable Target for the Treatment of This Rare Cancer

  • Hiroki Ozawa,
  • Naoki Haratake,
  • Ayako Nakashoji,
  • Tatsuaki Daimon,
  • Atrayee Bhattacharya,
  • Keyi Wang,
  • Keisuke Shigeta,
  • Atsushi Fushimi,
  • Kazumasa Fukuda and
  • Donald Kufe
  • + 5 authors

Patients with pancreatic neuroendocrine tumors (pNETs) have limited access to effective targeted agents and invariably succumb to progressive disease. MUC1-C is a druggable oncogenic protein linked to driving pan-cancers. There is no known involvemen...

  • Article
  • Open Access
11 Citations
3,272 Views
15 Pages

Prediction of Pathological Grades of Pancreatic Neuroendocrine Tumors Based on Dynamic Contrast-Enhanced Ultrasound Quantitative Analysis

  • Dao-Hui Yang,
  • Juan Cheng,
  • Xiao-Fan Tian,
  • Qi Zhang,
  • Ling-Yun Yu,
  • Yi-Jie Qiu,
  • Xiu-Yun Lu,
  • Wen-Hui Lou,
  • Yi Dong and
  • Wen-Ping Wang

Objective: To investigate whether the dynamic contrast-enhanced ultrasound (DCE-US) analysis and quantitative parameters could be helpful for predicting histopathologic grades of pancreatic neuroendocrine tumors (pNETs). Methods: This retrospective s...

  • Review
  • Open Access
34 Citations
5,524 Views
16 Pages

Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1

  • Francesca Marini,
  • Francesca Giusti,
  • Francesco Tonelli and
  • Maria Luisa Brandi

Pancreatic neuroendocrine tumors (pNETs) are a rare group of cancers accounting for about 1–2% of all pancreatic neoplasms. About 10% of pNETs arise within endocrine tumor syndromes, such as Multiple Endocrine Neoplasia type 1 (MEN1). pNETs affect 30...

  • Case Report
  • Open Access
1 Citations
3,192 Views
9 Pages

Total Pancreatectomy for Multicentric Cystic Neuroendocrine Tumor of the Pancreas: A Case Report

  • Milica Mitrovic-Jovanovic,
  • Nikica Grubor,
  • Stefan Milosevic,
  • Aleksandra Jankovic,
  • Katarina Stosic,
  • Slavenko Ostojic,
  • Aleksandar Ninic,
  • Marjan Micev and
  • Jelena Djokic Kovac

Pancreatic neuroendocrine tumors (PNETs) are uncommon pancreatic neoplasms with malignant potential, heterogeneous clinical behavior, as well as imaging appearance. These tumors represent less than 3% of all pancreatic neoplasms with typical CT prese...

  • Article
  • Open Access
1 Citations
2,113 Views
12 Pages

When Should Lymphadenectomy Be Performed in Non-Metastatic Pancreatic Neuroendocrine Tumors? A Population-Based Analysis of the German Clinical Cancer Registry Group

  • Thaer S. A. Abdalla,
  • Louisa Bolm,
  • Monika Klinkhammer-Schalke,
  • Sylke Ruth Zeissig,
  • Kees Kleihues van Tol,
  • Peter Bronsert,
  • Stanislav Litkevych,
  • Kim C. Honselmann,
  • Rüdiger Braun and
  • Steffen Deichmann
  • + 4 authors

19 January 2024

Background: Patient selection for lymphadenectomy remains a controversial aspect in the treatment of pancreatic neuroendocrine tumors (pNETs), given the growing importance of parenchyma-sparing resections and minimally invasive procedures. Methods: T...

  • Article
  • Open Access
12 Citations
3,146 Views
21 Pages

Circulating miRNA Increases the Diagnostic Accuracy of Chromogranin A in Metastatic Pancreatic Neuroendocrine Tumors

  • Annamária Kövesdi,
  • Petra Anna Kurucz,
  • Gábor Nyírő,
  • Ottó Darvasi,
  • Attila Patócs and
  • Henriett Butz

2 September 2020

Chromogranin A (CgA) is the most widely accepted biomarker for neuroendocrine tumors (NET) but its diagnostic accuracy is dependent on tumor type and the use of proton-pump inhibitors (PPI). We investigated the diagnostic value of circulating miRNAs...

  • Review
  • Open Access
5 Citations
9,705 Views
35 Pages

Treatment of Pancreatic Neuroendocrine Tumors: Beyond Traditional Surgery and Targeted Therapy

  • Khyati Bidani,
  • Angela G. Marinovic,
  • Vishali Moond,
  • Prateek Harne,
  • Arkady Broder and
  • Nirav Thosani

13 May 2025

Pancreatic neuroendocrine tumors (PNETs) are a rare subset of pancreatic neoplasms with diverse biological behavior and clinical presentations. Traditional treatment approaches, such as surgery and targeted therapies, have significantly improved outc...

  • Brief Report
  • Open Access
6 Citations
2,794 Views
8 Pages

Report of a Novel Molecular Profile in Malignant Insulinoma

  • Laura Burns,
  • Bita Naimi,
  • Matthew Ronan,
  • Huihong Xu and
  • Horst Christian Weber

6 February 2023

Pancreatic neuroendocrine tumors, or pNETs, represent a rare and clinically heterogenous subset of pancreatic neoplasms. One such pNET, the insulinoma, is found to be malignant in just 4% of all insulinomas. Due to the exceedingly uncommon occurrence...

  • Systematic Review
  • Open Access
7 Citations
3,863 Views
13 Pages

Pancreatic Neuroendocrine Tumors: What Is the Best Surgical Option?

  • Renato Patrone,
  • Federico Maria Mongardini,
  • Alessandra Conzo,
  • Chiara Cacciatore,
  • Giovanni Cozzolino,
  • Antonio Catauro,
  • Eduardo Lanza,
  • Francesco Izzo,
  • Andrea Belli and
  • Giovanni Conzo
  • + 4 authors

20 May 2024

Background: Pancreatic neuroendocrine tumors (pNETs) represent a rare subset of pancreatic cancer. Functional tumors cause hormonal changes and clinical syndromes, while non-functional ones are often diagnosed late. Surgical management needs multidis...

  • Article
  • Open Access
8 Citations
3,567 Views
24 Pages

Serum Metabolite Biomarkers for Pancreatic Tumors: Neuroendocrine and Pancreatic Ductal Adenocarcinomas—A Preliminary Study

  • Karolina Skubisz,
  • Krzysztof Dąbkowski,
  • Emilia Samborowska,
  • Teresa Starzyńska,
  • Anna Deskur,
  • Filip Ambrozkiewicz,
  • Jakub Karczmarski,
  • Mariusz Radkiewicz,
  • Katarzyna Kusnierz and
  • Agnieszka Paziewska
  • + 3 authors

19 June 2023

Background: Pancreatic cancer is the most common pancreatic solid malignancy with an aggressive clinical course and low survival rate. There are a limited number of reliable prognostic biomarkers and a need to understand the pathogenesis of pancreati...

  • Case Report
  • Open Access
3 Citations
2,599 Views
6 Pages

Hyperammonemia can lead to encephalopathy and may be accompanied by a diagnostic dilemma. Imaging as well as biochemical analyses are the cornerstone for identifying possible underlying causes such as severe liver disease or urea cycle defect. We rep...

  • Article
  • Open Access
51 Citations
4,510 Views
18 Pages

Semi-ProtoPNet Deep Neural Network for the Classification of Defective Power Grid Distribution Structures

  • Stefano Frizzo Stefenon,
  • Gurmail Singh,
  • Kin-Choong Yow and
  • Alessandro Cimatti

27 June 2022

Power distribution grids are typically installed outdoors and are exposed to environmental conditions. When contamination accumulates in the structures of the network, there may be shutdowns caused by electrical arcs. To improve the reliability of th...

  • Article
  • Open Access
9 Citations
2,741 Views
15 Pages

CenterPNets: A Multi-Task Shared Network for Traffic Perception

  • Guangqiu Chen,
  • Tao Wu,
  • Jin Duan,
  • Qi Hu,
  • Dandan Huang and
  • Hao Li

23 February 2023

The importance of panoramic traffic perception tasks in autonomous driving is increasing, so shared networks with high accuracy are becoming increasingly important. In this paper, we propose a multi-task shared sensing network, called CenterPNets, th...

  • Article
  • Open Access
1,712 Views
11 Pages

Safety and Efficacy of Radiofrequency Ablation in Management of Various Pancreatic Neoplasms

  • Varshita Goduguchinta,
  • Mohamed Ebrahim,
  • Raahi Patel,
  • Navkiran Randhawa,
  • Ahamed Khalyfa,
  • Mahnoor Inamullah,
  • Rahil Desai and
  • Kamran Ayub

4 June 2025

Background/Objectives: Pancreatic neoplasms, including adenocarcinoma, pancreatic neuroendocrine tumors (pNETs), intraductal papillary mucinous neoplasms (IPMNs), and high-grade cystic lesions, often require surgical resection as a form of curative t...

  • Article
  • Open Access
4 Citations
2,077 Views
13 Pages

Treatment Assessment of pNET and NELM after Everolimus by Quantitative MRI Parameters

  • Maria Ingenerf,
  • Sophia Kiesl,
  • Michael Winkelmann,
  • Christoph J. Auernhammer,
  • Johannes Rübenthaler,
  • Freba Grawe,
  • Matthias P. Fabritius,
  • Jens Ricke and
  • Christine Schmid-Tannwald

Assessment of treatment response to targeted therapies such as everolimus is difficult, especially in slow-growing tumors such as NETs. In this retrospective study, 17 patients with pancreatic neuroendocrine tumors (pNETs) and hepatic metastases (NEL...

  • Article
  • Open Access
381 Views
22 Pages

4 January 2026

Rotated Bounding Boxes (RBBs) for oriented object detection are labor-intensive and time-consuming to annotate. Single-point supervision offers a cost-effective alternative but suffers from insufficient size and orientation information, leading exist...

  • Article
  • Open Access
8 Citations
3,071 Views
14 Pages

Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian Cohort

  • Francesco Panzuto,
  • Elisa Andrini,
  • Giuseppe Lamberti,
  • Sara Pusceddu,
  • Maria Rinzivillo,
  • Fabio Gelsomino,
  • Alessandra Raimondi,
  • Alberto Bongiovanni,
  • Maria Vittoria Davì and
  • Davide Campana
  • + 6 authors

3 April 2024

Background: The optimal treatment sequencing for advanced, well-differentiated pancreatic neuroendocrine tumors (pNETs) is unknown. We performed a multicenter, retrospective study to evaluate the best treatment sequence in terms of progression-free s...

  • Article
  • Open Access
552 Views
22 Pages

Minimally Invasive Resection of Occult Insulinomas—Experience from an ENETS Centre of Excellence and Review of the Literature

  • Alina S. Ritter,
  • Feline Ockenga,
  • Kira C. Steinkraus,
  • Jelte Poppinga,
  • Philipp H. von Kroge,
  • Tania Amin,
  • Fabrice Viol,
  • Thorben W. Fründt,
  • Felix Nickel and
  • Anna Nießen
  • + 1 author

30 November 2025

Background/Objectives: Insulinomas are rare insulin-secreting pancreatic neuroendocrine tumours (pNETs). Preoperative tumour localisation can usually be achieved by computed tomography (CT), magnetic resonance imaging, or positron emission tomography...

  • Article
  • Open Access
20 Citations
4,210 Views
18 Pages

Shifts in Forest Species Composition and Abundance under Climate Change Scenarios in Southern Carpathian Romanian Temperate Forests

  • Juan García-Duro,
  • Albert Ciceu,
  • Serban Chivulescu,
  • Ovidiu Badea,
  • Mihai A. Tanase and
  • Cristina Aponte

21 October 2021

The structure and functioning of temperate forests are shifting due to changes in climate. Foreseeing the trajectory of such changes is critical to implementing adequate management practices and defining long-term strategies. This study investigated...

  • Article
  • Open Access
2,295 Views
10 Pages

Treatment Patterns of Pancreatic Neuroendocrine Tumor (pNET) Patients at Two Canadian Cancer Centres

  • Gautham Nair,
  • Morgan Black,
  • Kathie Baer,
  • Stephen Welch,
  • David T. Laidley,
  • Rachel Goodwin,
  • Macyn Leung,
  • William J. Phillips,
  • Michael Vickers and
  • Elena Tsvetkova
  • + 2 authors

Pancreatic neuroendocrine tumors (pNETs) are rare but increasingly prevalent malignancies with varied prognoses and a diverse range of treatment options, including surgery, somatostatin analogues (SSAs), chemotherapy, targeted therapy, and peptide re...

  • Article
  • Open Access
477 Views
24 Pages

X2P-Net: Context-Aware 2D/3D Vertebra Localization

  • Rong Tao,
  • Kangqing Ye,
  • Weijun Zhang,
  • Wenyuan Sun,
  • Derong Yu,
  • Donghua Hang and
  • Guoyan Zheng

In the context of minimally invasive spine surgery, accurately estimating the 3D coordinates of the vertebrae from intraoperative 2D X-ray images is crucial for aligning preoperative data with the patient’s real-time posture. However, existing...

  • Feature Paper
  • Review
  • Open Access
38 Citations
4,910 Views
16 Pages

SIOP PNET5 MB Trial: History and Concept of a Molecularly Stratified Clinical Trial of Risk-Adapted Therapies for Standard-Risk Medulloblastoma

  • Martin Mynarek,
  • Till Milde,
  • Laetitia Padovani,
  • Geert O. Janssens,
  • Robert Kwiecien,
  • Veronique Mosseri,
  • Steven C. Clifford,
  • François Doz and
  • Stefan Rutkowski

2 December 2021

Background. SIOP PNET5 MB was initiated in 2014 as the first European trial using clinical, histological, and molecular parameters to stratify treatments for children and adolescents with standard-risk medulloblastoma. Methods. Stratification by upfr...

  • Article
  • Open Access
22 Citations
5,425 Views
22 Pages

ReID-DeePNet: A Hybrid Deep Learning System for Person Re-Identification

  • Hussam J. Mohammed,
  • Shumoos Al-Fahdawi,
  • Alaa S. Al-Waisy,
  • Dilovan Asaad Zebari,
  • Dheyaa Ahmed Ibrahim,
  • Mazin Abed Mohammed,
  • Seifedine Kadry and
  • Jungeun Kim

28 September 2022

Person re-identification has become an essential application within computer vision due to its ability to match the same person over non-overlapping cameras. However, it is a challenging task because of the broad view of cameras with a large number o...

  • Article
  • Open Access
49 Citations
5,416 Views
18 Pages

EfficientPNet—An Optimized and Efficient Deep Learning Approach for Classifying Disease of Potato Plant Leaves

  • Tahira Nazir,
  • Muhammad Munwar Iqbal,
  • Sohail Jabbar,
  • Ayyaz Hussain and
  • Mubarak Albathan

The potato plant is amongst the most significant vegetable crops farmed worldwide. The output of potato crop production is significantly reduced by various leaf diseases, which poses a danger to the world’s agricultural production in terms of b...

  • Article
  • Open Access
7 Citations
2,705 Views
21 Pages

Study of a QueryPNet Model for Accurate Detection and Segmentation of Goose Body Edge Contours

  • Jiao Li,
  • Houcheng Su,
  • Xingze Zheng,
  • Yixin Liu,
  • Ruoran Zhou,
  • Linghui Xu,
  • Qinli Liu,
  • Daixian Liu,
  • Zhiling Wang and
  • Xuliang Duan

2 October 2022

With the rapid development of computer vision, the application of computer vision to precision farming in animal husbandry is currently a hot research topic. Due to the scale of goose breeding continuing to expand, there are higher requirements for t...

  • Article
  • Open Access
11 Citations
5,674 Views
20 Pages

AttPNet: Attention-Based Deep Neural Network for 3D Point Set Analysis

  • Yufeng Yang,
  • Yixiao Ma,
  • Jing Zhang,
  • Xin Gao and
  • Min Xu

23 September 2020

Point set is a major type of 3D structure representation format characterized by its data availability and compactness. Most former deep learning-based point set models pay equal attention to different point set regions and channels, thus having limi...

  • Article
  • Open Access
16 Citations
2,796 Views
13 Pages

Added Value of Tomoelastography for Characterization of Pancreatic Neuroendocrine Tumor Aggressiveness Based on Stiffness

  • Emin Gültekin,
  • Christoph Wetz,
  • Jürgen Braun,
  • Dominik Geisel,
  • Christian Furth,
  • Bernd Hamm,
  • Ingolf Sack and
  • Stephan R. Marticorena Garcia

15 October 2021

Purpose: To evaluate the diagnostic performance of tomoelastography in differentiating pancreatic neuroendocrine tumors (PNETs) from healthy pancreatic tissue and to assess the prediction of tumor aggressiveness by correlating PNET stiffness with PET...

  • Article
  • Open Access
8 Citations
3,169 Views
18 Pages

5 November 2022

Cases of pancreatic neuroendocrine tumors (PNETs) are growing in number, and new treatment options are needed in order to improve patient outcomes. The mitogen-activated protein kinase-activated protein kinase 2 (MK2) is a crucial regulator of cytoki...

  • Article
  • Open Access
7 Citations
3,342 Views
11 Pages

8 March 2023

Von Hippel–Lindau (VHL) disease diagnosis is based on two criteria sets: International criteria (IC, two hemangioblastomas, one hemangioblastoma plus one visceral lesion, or VHL family history/pathogenic variant plus hemangioblastoma/visceral l...

  • Review
  • Open Access
9 Citations
4,963 Views
14 Pages

Impact of Diabetes Mellitus in Patients with Pancreatic Neuro-Endocrine Tumors: Causes, Consequences, and Future Perspectives

  • Lorena Hernandez-Rienda,
  • Maria Isabel del Olmo-García and
  • Juan Francisco Merino-Torres

11 November 2022

Diabetes mellitus (DM) and pancreatic neuroendocrine tumors (pNETs) are two entities closely linked together. DM has been described as a risk factor for the development of pNETs and for the aggressiveness of the disease. On the other hand, DM due to...

  • Review
  • Open Access
2,075 Views
11 Pages

Background: Poorly differentiated neuroendocrine tumors of the pancreas (pd-PNETs) are very rare tumors. Differentiating primary pd-PNET from neuroendocrine carcinomas, which metastasize to the pancreas, can be difficult. We will refer to any neuroen...

  • Review
  • Open Access
11 Citations
6,245 Views
35 Pages

Pancreatic Neuroendocrine Tumors: Signaling Pathways and Epigenetic Regulation

  • Zena Saleh,
  • Matthew C. Moccia,
  • Zachary Ladd,
  • Upasana Joneja,
  • Yahui Li,
  • Francis Spitz,
  • Young Ki Hong and
  • Tao Gao

22 January 2024

Pancreatic neuroendocrine tumors (PNETs) are characterized by dysregulated signaling pathways that are crucial for tumor formation and progression. The efficacy of traditional therapies is limited, particularly in the treatment of PNETs at an advance...

  • Review
  • Open Access
5 Citations
9,694 Views
10 Pages

Molecular Pathogenesis of Pancreatic Neuroendocrine Tumors

  • Florian Ehehalt,
  • Ellen Franke,
  • Christian Pilarsky and
  • Robert Grützmann

18 November 2010

Pancreatic neuroendocrine tumors (PNETs) are rare primary neoplasms of the pancreas and arise sporadically or in the context of genetically determined syndromes. Depending on hormone production and sensing, PNETs clinically manifest due to a hormone-...

  • Review
  • Open Access
26 Citations
7,721 Views
22 Pages

Surgical Management of Pancreatic Neuroendocrine Tumors

  • Megan L. Sulciner and
  • Thomas E. Clancy

28 March 2023

Pancreatic neuroendocrine tumors (PNETs) are relatively uncommon malignancies, characterized as either functional or nonfunctional secondary to their secretion of biologically active hormones. A wide range of clinical behavior can be seen, with the p...

  • Article
  • Open Access
8 Citations
4,681 Views
18 Pages

RABL6A Promotes Pancreatic Neuroendocrine Tumor Angiogenesis and Progression In Vivo

  • Chandra K. Maharjan,
  • Shaikamjad Umesalma,
  • Courtney A. Kaemmer,
  • Viviane P. Muniz,
  • Casey Bauchle,
  • Sarah L. Mott,
  • K. D. Zamba,
  • Patrick Breheny,
  • Mariah R. Leidinger and
  • Dawn E. Quelle
  • + 3 authors

Pancreatic neuroendocrine tumors (pNETs) are difficult-to-treat neoplasms whose incidence is rising. Greater understanding of pNET pathogenesis is needed to identify new biomarkers and targets for improved therapy. RABL6A, a novel oncogenic GTPase, i...

  • Review
  • Open Access
12 Citations
7,481 Views
16 Pages

Multimodal Management of Grade 1 and 2 Pancreatic Neuroendocrine Tumors

  • Ugo Marchese,
  • Martin Gaillard,
  • Anna Pellat,
  • Stylianos Tzedakis,
  • Einas Abou Ali,
  • Anthony Dohan,
  • Maxime Barat,
  • Philippe Soyer,
  • David Fuks and
  • Romain Coriat

15 January 2022

Pancreatic neuroendocrine tumors (p-NETs) are rare tumors with a recent growing incidence. In the 2017 WHO classification, p-NETs are classified into well-differentiated (i.e., p-NETs grade 1 to 3) and poorly differentiated neuroendocrine carcinomas...

  • Article
  • Open Access
4 Citations
1,523 Views
20 Pages

Automatic Counting and Location of Rice Seedlings in Low Altitude UAV Images Based on Point Supervision

  • Cheng Li,
  • Nan Deng,
  • Shaowei Mi,
  • Rui Zhou,
  • Yineng Chen,
  • Yuezhao Deng and
  • Kui Fang

28 November 2024

The number of rice seedlings and their spatial distribution are the main agronomic components for determining rice yield. However, the above agronomic information is manually obtained through visual inspection, which is not only labor-intensive and t...

  • Article
  • Open Access
24 Citations
6,229 Views
19 Pages

PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine Tumors

  • Gabriel Mpilla,
  • Amro Aboukameel,
  • Irfana Muqbil,
  • Steve Kim,
  • Rafic Beydoun,
  • Philip A. Philip,
  • Ramzi M. Mohammad,
  • Mandana Kamgar,
  • Vinod Shidham and
  • Asfar S. Azmi
  • + 6 authors

29 November 2019

Pancreatic neuroendocrine tumors (PNET) remain an unmet clinical need. In this study, we show that targeting both nicotinamide phosphoribosyltransferase (NAMPT) and p21-activated kinase 4 (PAK4) could become a synthetic lethal strategy for PNET. The...

  • Review
  • Open Access
25 Citations
5,370 Views
17 Pages

Surgical Management of Neuroendocrine Tumours of the Pancreas

  • Regis Souche,
  • Christian Hobeika,
  • Elisabeth Hain and
  • Sebastien Gaujoux

16 September 2020

Neuroendocrine tumours of the pancreas (pNET) are rare, accounting for 1–2% of all pancreatic neoplasms. They develop from pancreatic islet cells and cover a wide range of heterogeneous neoplasms. While most pNETs are sporadic, some are associa...

  • Article
  • Open Access
2 Citations
2,004 Views
7 Pages

Bone Loss in Patients with Pancreatic Neuroendocrine Tumors

  • He Tong,
  • Miaomiao Wang,
  • Jingjing Liu,
  • Chuangen Guo,
  • Zhongqiu Wang,
  • Jianhua Wang and
  • Xiao Chen

12 November 2022

Background: Pancreatic diseases may affect nutritional status, which is one of the important associated factors of bone health. High prevalence of osteoporosis or osteopenia has been reported in patients with pancreatitis. The bone loss in pancreatic...

  • Article
  • Open Access
14 Citations
2,268 Views
4 Pages

1 August 2019

Extraosseous Ewing sarcoma is a rare, poorly differentiated round-cell tumour that is part of the Ewing sarcoma family of tumours. Here, we present an extremely rare case of primary extraosseous Ewing sarcoma arising in the larynx, with distant metas...

  • Article
  • Open Access
3 Citations
1,700 Views
13 Pages

Background: Pancreatic neuroendocrine neoplasms (PNENs) are rare but clinically significant tumors with variable radiological presentations that complicate diagnosis. While typical PNENs are well characterized, atypical features, such as cystic or hy...

  • Review
  • Open Access
1,854 Views
17 Pages

Surgical Strategies for Tumors of the Pancreas and Duodenum

  • Rosyli F. Reveron-Thornton,
  • Kelly X. Huang,
  • Daniel Delitto,
  • Michael T. Longaker and
  • Jeffrey A. Norton

22 September 2025

The recommended surgery for pancreatic tumors is dependent on the diagnosis. For pancreatic adenocarcinoma, duodenal, and ampullary adenocarcinoma, a Whipple pancreaticoduodenectomy with lymph node dissection is recommended. For small < 2 cm or no...

  • Article
  • Open Access
5 Citations
3,486 Views
11 Pages

Survival Benefits of GLP-1 Receptor Agonists in Patients with Neuroendocrine Neoplasms: A Large-Scale Propensity-Matched Cohort Study

  • Manal S. Fawzy,
  • Awwad Alenezy,
  • Jessan A. Jishu,
  • Issa Khan,
  • Ahmad Dessouky,
  • Ahmed Abdelmaksoud,
  • Kristen E. Limbach and
  • Eman A. Toraih

7 May 2025

Background: Neuroendocrine neoplasms (NENs) represent a heterogeneous group of malignancies that consist of two major subtypes: neuroendocrine tumors (NETs) and neuroendocrine carcinomas (NECs). Glucagon-like peptide-1 receptor agonists (GLP-1Ra) hav...

of 3